Journeo plc (LON: JNEO), a provider of intelligent transport systems, has announced a significant contract win, securing purchase orders worth US$5.0 million to supply platform display systems for the Metropolitan Transportat

As Verizon Communications Inc. (NYSE: VZ) prepares to release its third-quarter 2025 earnings today, markets are keenly watching for signs of stability and growth amidst a period of significant transition. The telecommunicati

GSK (LON: GSK) delivered a robust third-quarter performance, prompting an upgrade to its full-year 2025 guidance and sending its shares over 3% higher at the open on Wednesday.

Next PLC (LON: NXT) significantly outperformed expectations in its third-quarter trading statement, leading to increased full-year profit guidance. The retailer's full-pri

Boeing stock (NYSE:BA) are trading at $224.50 in pre-market hours, up a modest 0.15% from the previous close. This comes ahead of the company's highly anticipated third-quarter 2025 earnings release, scheduled for tomorrow. W

Garmin Ltd. (NYSE: GRMN), the global leader in GPS technology, is preparing to release its third-quarter 2025 earnings report tomorrow, before the market opens. The report will be a crucial indicator of Garmin's performance a

Aston Martin (LON: AML) reported a challenging third quarter, reflecting previously disclosed lower wholesale volumes and macroeconomic pressures. Despite the current down

Etsy Inc. (NASDAQ: ETSY) is capturing Wall Street's attention as its stock price flirts with new 52-week highs ahead of its third-quarter 2025 earnings release, scheduled this morning. The stock is currently just over$76, hav

Elementis PLC (LON: ELM), a global specialty chemicals company, released its third-quarter trading update, showcasing a resilient performance amidst ongoing market challenges.

Visa Inc. (NYSE: V) is set to announce its fiscal fourth-quarter and full-year 2025 financial results today, after the market closes. The payments giant's earnings release is a closely watched event, offering valuable insight

Booking Holdings stock (NASDAQ:BKNG) is trading at around $5,191 in today'session, a modest increase of 1.50% in the last five days. The online travel giant is on the cusp of releasing its third-quarter earnings report tomorr

Enphase Energy Inc. (NASDAQ: ENPH), a prominent player in the microinverter-based solar and battery systems arena, is set to unveil its third-quarter 2025 financial results tomorrow, after market close. The report arrives at

The Cheesecake Factory Incorporated (NASDAQ: CAKE) is poised to release its third-quarter fiscal 2025 earnings after market close today. The company will host a conference call at 2:00 p.m. Pacific Time to discuss the results

Mondelez International Inc. (NASDAQ: MDLZ), the global snacking giant, is set to release its third-quarter 2025 financial results after market close today, with a conference call scheduled for 5:00 p.m. ET. Analysts are keenl

Small-cap stocks are set to outperform larger peers over the coming years as interest rate cuts and broader economic growth revive earnings in rate-sensitive sectors, according to Brent Schutte, chief investment officer at No

genedrive plc (LSE: GDR) witnessed a significant jump in its share price following the announcement of a Memorandum of Understanding (MOU) with the Kingdom of Saudi Arabia (KSA) Ministry of Health (MOH).

Jefferies has initiated coverage of two of Britain’s largest pharmaceutical companies, GSK and AstraZeneca, with Buy ratings, citing strong pipelines and potential for long-term growth across their core businesses.

REACT Group Plc (AIM: REAT), a specialist support services provider, has announced a robust trading update for the year ended September 30, 2025 (FY25). The company's perf

evoke Plc (LSE: EVOK), a global betting and gaming leader, announced a 5% increase in revenue for Q3 2025, reaching £435 million. This marks the fifth consecutive quarter of year-over-year revenue growth, driven by positive p

GSK plc (LON: GSK) announced its B7-H3-targeted antibody-drug conjugate (ADC), GSK'227, has been granted Orphan Drug Designation (ODD) by the European Medicines Agency (EMA) for pulmonary neuroendocrine carcinoma (NEC), a cat